XML 48 R8.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Class A Common Stock
Common Stock
Class A Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Non-Controlling Interest
Beginning of period (in shares) at Mar. 31, 2019       159,924,825 (19,896,972)          
Beginning of period at Mar. 31, 2019 $ 675,366     $ 1,599 $ (711,450) $ 401,596 $ 994,811   $ (11,190) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Issuance of common stock (in shares)       833,258            
Issuance of common stock 14,987     $ 8   14,979        
Stock options exercised (in shares)       575,890            
Stock options exercised 8,925     $ 6   8,919        
Repurchase of common stock (in shares)         (2,717,080)          
Repurchase of common stock (186,645)       $ (186,645)          
Recognition of liability related to future restricted stock units vesting (757)         (757)        
Net income $ 482,603           482,603      
Accounting Standards Update [Extensible List] Accounting Standards Update 2016-13 [Member]                  
Other comprehensive income, net of tax $ (34,811)               (34,811)  
Dividends paid (146,602)           (146,602)      
Stock-based compensation expense 43,290         43,290        
End of period (shares) at Mar. 31, 2020       161,333,973 (22,614,052)          
End of period at Mar. 31, 2020 856,356 $ (1,180)   $ 1,613 $ (898,095) 468,027 1,330,812 $ (1,180) (46,001) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Issuance of common stock (in shares)       1,112,183            
Issuance of common stock 18,814     $ 11   18,803        
Stock options exercised (in shares)       504,450            
Stock options exercised 11,747     $ 5   11,742        
Repurchase of common stock (in shares)     (3,800,000)   (4,090,525)          
Repurchase of common stock (318,068)       $ (318,068)          
Recognition of liability related to future restricted stock units vesting (456)         (456)        
Net income 608,958           608,958      
Other comprehensive income, net of tax 16,230               16,230  
Dividends paid (181,066)           (181,066)      
Stock-based compensation expense 59,841         59,841        
End of period (shares) at Mar. 31, 2021       162,950,606 (26,704,577)          
End of period at Mar. 31, 2021 1,071,176     $ 1,629 $ (1,216,163) 557,957 1,757,524   (29,771) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Issuance of common stock (in shares)       1,224,207            
Issuance of common stock 22,170     $ 15   22,155        
Stock options exercised (in shares)       197,732            
Stock options exercised 5,929     $ 2   5,927        
Repurchase of common stock (in shares)     (4,700,000)   (5,083,620)          
Repurchase of common stock (419,291)       $ (419,291)          
Recognition of liability related to future restricted stock units vesting 1,213         1,213        
Net income 466,577           466,740     (163)
Other comprehensive income, net of tax 38,356               38,356  
Dividends paid (209,193)           (209,193)      
Stock-based compensation expense 69,784         69,784        
Contribution to non-controlling interest 0         (814)       814
End of period (shares) at Mar. 31, 2022       164,372,545 (31,788,197)          
End of period at Mar. 31, 2022 $ 1,046,721     $ 1,646 $ (1,635,454) $ 656,222 $ 2,015,071   $ 8,585 $ 651